Jaguar Health (JAGX) Share-based Compensation (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Share-based Compensation of $452.0 million for Q1 2026, up 132451.32% year-over-year from N/an in Q1 2025, and up 92144.9% quarter-over-quarter from $490000.0 in Q4 2025.
Jaguar Health (JAGX) Share-based Compensation (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Share-based Compensation for 13 consecutive years, with $452.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 132451.32% year-over-year to $452.0 million; the TTM figure through Mar 2026 stood at $452.0 million (up 18303.91% YoY), while the FY2025 annual figure was $569.0 million, down 99.92% from the prior year.
- Share-based Compensation rose to $452.0 million in Q1 2026 per JAGX's latest filing, from $490000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $452.0 million in Q1 2026 and bottomed at $90000.0 in Q1 2022.
- Historically, Share-based Compensation has averaged $52.3 million across 5 years, with a median of $490000.0 in 2025.
- Annual changes were most pronounced in 2022 — Share-based Compensation sank 87.57% — and 2025, when it jumped 138287.1%.
- Jaguar Health's Share-based Compensation stood at $142000.0 in 2022, then jumped by 306.34% to $577000.0 in 2023, then surged by 146.45% to $1.4 million in 2024, then slumped by 65.54% to $490000.0 in 2025, then surged by 92144.9% to $452.0 million in 2026.
- Business Quant data shows JAGX's Share-based Compensation at $452.0 million in Q1 2026, $490000.0 in Q4 2025, and $429.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | - |
| 10 | Jaguar Health | 448,735.56 | -9.62 Mn | 19.11 Mn | 452.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 452.00 Mn |
| Mar 31, 2026 | 452.00 Mn |
| Dec 31, 2025 | 490,000.00 |
| Dec 31, 2025 | 490,000.00 |
| Sep 30, 2025 | 429.00 Mn |
| Sep 30, 2025 | 429.00 Mn |
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 310,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 221,000.00 |
| Mar 31, 2024 | 221,000.00 |
| Dec 31, 2023 | 577,000.00 |
| Dec 31, 2023 | 577,000.00 |